PFI

Pfizer Stock

StockStock
ISIN: INE182A01018
Ticker: PFIZER
INE182A01018
PFIZER

Price

Historical dividends and forecast

All dividend data

Pfizer has so far distributed 0.417 in 2024. The next dividend will be paid on 05.09.2025


0.94

CHART BY

Frequently asked questions

What is Pfizer's market capitalization?

The market capitalization of Pfizer is $2.82B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Pfizer's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Pfizer is 38.56. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Pfizer?

Pfizer's Earnings Per Share (EPS) over the trailing twelve months (TTM) is 1.60. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Pfizer's stock?

Currently, 3 analysts cover Pfizer's stock, with a consensus target price of $56.07. Analyst ratings provide insights into the stock's expected performance.

What is Pfizer's revenue over the trailing twelve months?

Over the trailing twelve months, Pfizer reported a revenue of $265.15M.

What is the EBITDA for Pfizer?

Pfizer's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $83.96M. EBITDA measures the company's overall financial performance.

What is the 5-year beta of Pfizer's stock?

The 5-year beta for Pfizer is 0.45. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Pfizer have, and what sector and industry does it belong to?

Pfizer employs approximately 1,721 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of Pfizer's shares?

The free float of Pfizer is 15.14M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 
$2.82B

5Y beta

 
0.45

EPS (TTM)

 
1.60

Free Float

 
15.14M

P/E ratio (TTM)

 
38.56

Revenue (TTM)

 
$265.15M

EBITDA (TTM)

 
$83.96M

Analyst Ratings

The price target is $56.07 and the stock is covered by 3 analysts.

Buy

2

Hold

1

Sell

0

Information

Pfizer Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing, marketing, trading and export of pharmaceutical products. The Company has its own manufacturing facility at Goa. The Company has various independent contract/third party manufacturers based across India. Its product portfolio includes vaccine, anti-infectives, cardiac, pain, maternal nutrition, gastrointestinal, contraceptives, anti-inflammatory, nutrition and immunity, and respiratory. The Company's vaccine business is focused on Prevenar 13, a pneumococcal conjugate vaccine that is administered to infants who are six weeks and older as part of primary vaccination, toddlers, adolescents, adults, and elderly population. Its inflammation and immunology portfolio includes two advanced therapies, which cater to patients suffering from diseases related to chronic immune system such as rheumatoid arthritis, ankylosing spondylitis, juvenile idiopathic arthritis, psoriasis and ulcerative colitis.

1,721

Biotechnology & Drugs

Health Care

Identifier

ISIN

INE182A01018

Primary Ticker

PFIZER

Knockouts

Join the conversation